Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass layoffs — 40% of ...

The company has faced additional struggles over the past several months, including the resignations in September of the seven ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Wojcicki attempted to take 23andMe private, proposing an official offer to the board of directors in late July. However, the board quickly rejected the offer, and seven independent directors resigned, ...

23andMe's CEO called the decision to lay off 200 employees ... The suffering company faced another blow in September when its board of directors resigned. The board’s seven members quit after Wojcicki ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...

The restructuring arrives during a period of turmoil at South San Francisco-based 23andMe, which has recently included a high ...

Sales for the Atlanta-based company improved 6.6 percent to $40.22 billion, topping the $39.31 billion that analysts ...